BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19145879)

  • 1. [Nonalcoholic fatty liver disease and insulin resistance: clinical, biochemical, and morphological parallels].
    Zvenigorodskaia LA; Drozdov VN; Egorova EG
    Eksp Klin Gastroenterol; 2008; (3):25-30. PubMed ID: 19145879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].
    Lazebnik LB; Zvenigorodskaia LA; Egorova EG; Mel'nikova NV; Khomeriki SG
    Eksp Klin Gastroenterol; 2009; (8):4-11. PubMed ID: 20469672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current therapy strategies for nonalcoholic fatty liver disease].
    Fang JW; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):120-2. PubMed ID: 12648420
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and bariatric surgery: a review.
    Helling TS; Gurram K
    Surg Obes Relat Dis; 2006; 2(2):213-20. PubMed ID: 16925347
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver NF-kappaB and AP-1 DNA binding in obese patients.
    Videla LA; Tapia G; Rodrigo R; Pettinelli P; Haim D; Santibañez C; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Castillo J; Korn O; Maluenda F; Díaz JC; Rencoret G; Poniachik J
    Obesity (Silver Spring); 2009 May; 17(5):973-9. PubMed ID: 19165171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of nonalcoholic fatty liver disease with serum adiponectin and insulin resistance].
    Shi SL; Nie YQ; Li YY; Zhou YJ; Ma JX
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):58-9. PubMed ID: 17244464
    [No Abstract]   [Full Text] [Related]  

  • 8. A lean man with nonalcoholic fatty liver disease.
    Tanaka N; Yazaki M; Kobayashi K
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):A32. PubMed ID: 16901765
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease.
    van Geenen EJ; Smits MM; Schreuder TC; van der Peet DL; Bloemena E; Mulder CJ
    Pancreas; 2010 Nov; 39(8):1185-90. PubMed ID: 20871475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between tumor necrosis factor-alpha gene polymorphism and insulin resistance in nonalcoholic fatty liver disease].
    Huang J; Li YY; Zhou YJ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):613-5. PubMed ID: 16938178
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
    Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
    Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of leptin resistance and insulin resistance in subjects with nonalcoholic fatty liver].
    Ma XH; Wang WM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):651, 655. PubMed ID: 15623370
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis, clinical aspects and development of fatty liver].
    Eitel B; Kleine FD; Kleine S
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(3):111-6. PubMed ID: 4042954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism in alcohol-induced fatty liver. Evidence for an abnormal insulin response to glucagon in alcoholic liver disease.
    Rehfeld JF; Juhl E; Hilden M
    Gastroenterology; 1973 Mar; 64(3):445-51. PubMed ID: 4691595
    [No Abstract]   [Full Text] [Related]  

  • 16. The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?
    Vanni E; Bugianesi E
    Hepatology; 2009 Jun; 49(6):1790-2. PubMed ID: 19475679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent topics on nonalcoholic steatohepatitis].
    Saibara T; Onishi S; enzan H
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1104-9. PubMed ID: 12866461
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of resistin expression in livers of patients with nonalcoholic fatty liver disease].
    Zhao CY; Kong LB; Wang YD
    Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):630-1. PubMed ID: 18752757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver pathology in gout].
    Tremel R; Pohl W
    Med Klin; 1971 May; 66(21):777-81. PubMed ID: 5578660
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.